The store will not work correctly when cookies are disabled.
1-[(3-naphthalen-2-yl)-5-N,N-dimethylamino-(1,2,4-triazol-4-yl)]-3-phenol
ID: ALA377643
PubChem CID: 11558993
Max Phase: Preclinical
Molecular Formula: C20H18N4O
Molecular Weight: 330.39
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CN(C)c1nnc(-c2ccc3ccccc3c2)n1-c1cccc(O)c1
Standard InChI: InChI=1S/C20H18N4O/c1-23(2)20-22-21-19(24(20)17-8-5-9-18(25)13-17)16-11-10-14-6-3-4-7-15(14)12-16/h3-13,25H,1-2H3
Standard InChI Key: RQQBVBFYGSVQNK-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
-0.3330 -24.4629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5951 -23.7976 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.9249 -23.3051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1883 -22.5181 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.0182 -22.5247 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.2689 -23.3159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2067 -23.7014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1918 -24.5282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4695 -24.9268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5035 -23.2751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5915 -24.6202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3054 -25.0372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.3003 -25.8622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5820 -26.2712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8672 -25.8491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8758 -25.0255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1479 -26.2548 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.7807 -23.6700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7627 -24.4965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0391 -24.8924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3551 -23.6333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0792 -23.2412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.0524 -23.5769 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.6689 -23.0293 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2207 -24.3860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3 4 2 0
12 13 1 0
13 14 2 0
7 8 2 0
14 15 1 0
2 3 1 0
15 16 2 0
16 11 1 0
2 11 1 0
8 9 1 0
15 17 1 0
9 19 2 0
4 5 1 0
18 19 1 0
18 10 2 0
19 20 1 0
20 1 2 0
10 7 1 0
1 21 1 0
3 7 1 0
21 22 2 0
22 18 1 0
5 6 2 0
6 23 1 0
6 2 1 0
23 24 1 0
11 12 2 0
23 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 330.39 | Molecular Weight (Monoisotopic): 330.1481 | AlogP: 3.86 | #Rotatable Bonds: 3 |
Polar Surface Area: 54.18 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.99 | CX Basic pKa: 2.27 | CX LogP: 4.28 | CX LogD: 4.28 |
Aromatic Rings: 4 | Heavy Atoms: 25 | QED Weighted: 0.62 | Np Likeness Score: -0.97 |
References
1. Zhang Q, Keenan SM, Peng Y, Nair AC, Yu SJ, Howells RD, Welsh WJ.. (2006) Discovery of novel triazole-based opioid receptor antagonists., 49 (14): [PMID:16821764] [10.1021/jm0601250] |